Cargando…
A case of pulmonary toxicity associated with G-CSF and doxorubicin administration
The cytokine growth factor, G-CSF (granulocyte colony-stimulating factor), is commonly used in oncologic practice and is generally believed to be a safe agent to administer. We describe here a case of pulmonary toxicity associated with the concurrent administration of G-CSF and doxorubicin. We cont...
Autores principales: | Eisenbeis, C. F., Winn, D., Poelman, S., Polsky, C. V., Rubenstein, J. H., Olopade, O. I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101872/ https://www.ncbi.nlm.nih.gov/pubmed/11261324 http://dx.doi.org/10.1007/s002770000232 |
Ejemplares similares
-
Time-dependent simvastatin administration enhances doxorubicin toxicity in neuroblastoma
por: Anderson, Colin C., et al.
Publicado: (2020) -
Long-term safety of filgrastim (rhG-CSF) administration
por: Confer, Dennis L, et al.
Publicado: (2007) -
Intrauterine G-CSF Administration in Recurrent Implantation Failure (RIF): An Rct
por: Kalem, Ziya, et al.
Publicado: (2020) -
CLOZAPINE-INDUCED AGRANULOCYTOSIS AND USE OF G-CSF
por: Srinivasan, T.N., et al.
Publicado: (1998) -
G-CSF and GM-CSF in clinical trials.
por: Antman, K. H.
Publicado: (1990)